The American Academy of Dermatology (Academy) reiterated the safety and effectiveness of sunscreens, including those with nanoparticles, to protect against the damaging effects from exposure to ultraviolet (UV) radiation.
ETH-Zurich researchers have devised a method to detect mutations in tumour cells that are only present in a proportion of the cancer's cells. The analysis reveals that cells of individual tumours are more variable than first thought - and differ from patient to patient.
Researchers have taken a step toward overcoming a key obstacle in commercializing "hyperbolic metamaterials," structures that could bring optical advances including ultrapowerful microscopes, computers and solar cells.
Researchers have created an ultrasensitive biosensor that could open up new opportunities for early detection of cancer and "personalized medicine" tailored to the specific biochemistry of individual patients.
Experts in nanosecurity at an international level discuss the regulatory framework of the nanotechnological industry in San Sebastian, on the 3 and 4 May, at the symposium: "Questions of security and regulatory challenges of the nanomaterials".
The European Technology Initiative, "Fuel Cells and Hydrogen Joint Undertaking" (FCH JU), is providing approx 2.3 million euro of finance for the development of new hydrogen solid-state containers on the basis of boron hydrides.
UniQuest, The University of Queensland's main commercialisation company, has facilitated a strategic research collaboration and antibody production agreement between Australian Institute for Bioengineering and Nanotechnology (AIBN) researchers and Biosceptre International Limited to develop a bioprocess for producing certain monoclonal antibodies for the treatment of cancer.